A B-Cell Receptor-Specific Selection Step Governs Immature to Mature B Cell Differentiation

Seventy percent of peripheral immature conventional (B2) B cells fail to develop into mature B cells. The nature of this cell loss has not been characterized; the process that governs which immature B cells develop into long-lived peripheral B cells could be either stochastic or selective. Here, we...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 97; no. 6; pp. 2743 - 2748
Main Authors Levine, Matthew H, Haberman, Ann M, Sant'Angelo, Derek B, Hannum, Lynn G
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences of the United States of America 14.03.2000
National Acad Sciences
National Academy of Sciences
The National Academy of Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Seventy percent of peripheral immature conventional (B2) B cells fail to develop into mature B cells. The nature of this cell loss has not been characterized; the process that governs which immature B cells develop into long-lived peripheral B cells could be either stochastic or selective. Here, we demonstrate that this step is in fact selective, in that the fate of an immature B cell is highly dependent on its Ig receptor specificity. A significant skewing of the B cell receptor repertoire occurs by the time cells enter the mature B cell fraction, which indicates that there is selection of only a minority of immature B cells to become mature B cells. Because only a few heavy-light chain pairs are enhanced of the diverse available repertoire, we favor the idea that selection is positive for these few heavy-light chain pairs rather than negative against nearly all others. Because most immature B cells are lost at this transition, this putative positive selection event is likely to be a major force shaping the mature B cell receptor repertoire available for adaptive immune responses.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
C.A.J. and M.J.S. contributed equally to this work.
Communicated by John W. Kappler, National Jewish Medical and Research Center, Denver, CO
To whom reprint requests should be addressed at: Yale University School of Medicine, Section of Immunobiology, P.O. Box 208011, 310 Cedar Street, LH 416, New Haven, CT 06520-8011. E-mail: mlevine@biomed.med.yale.edu.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.050552997